ClinicalTrials.Veeva

Menu

TAP Block: Does Volume Make a Difference?

McMaster University logo

McMaster University

Status

Completed

Conditions

Post-operative Pain

Treatments

Drug: Ropivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT01307215
10-3436

Details and patient eligibility

About

Patients who have abdominal surgery will experience pain from the incision. The lumbar TAP block is a procedure used to reach the nerve endings in the abdominal wall so that there is a reduction in pain after surgery. Using ultrasound guidance, a solution of ropivacaine will be injected after surgery. The aim of this study is to determine the effect of changes in the volume of the injection.

Full description

Pain from a surgical incision happens in most patients. During the perioperative period, the use of the TAP block has been shown to reduce pain scores, opioid consumption and sedation scores. Also, there is a trend towards a reduction of post-operative nausea and vomiting. The aim of the block is to reach the distal nerve endings of the abdominal wall from T6 to L1 dermatomes using ultrasound guidance with a single shot of ropivacaine at different volumes. Currently, there is consensus about optimal procedure-specific volumes and local anesthetic concentrations for lumbar TAP blocks. This is a pilot study and the purpose being is it feasible to do a large scale clinical study to determine the influence of increasing the local anesthetic volume.

Enrollment

31 patients

Sex

Female

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18-70 years old
  • total abdominal hysterectomy
  • capable of completing informed consent
  • no previous chronic opioid use
  • no previous abdominal wall surgeries

Exclusion criteria

  • patient refusal
  • contraindication to regional anesthesia: coagulopathy, anticoagulant use, bleeding disorders,
  • local or systemic infection
  • local anesthetic allergy
  • BMI>35

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Triple Blind

31 participants in 3 patient groups

20mLs of 0.5% ropivacaine per side
Experimental group
Treatment:
Drug: Ropivacaine
Drug: Ropivacaine
Drug: Ropivacaine
30mLs of 0.33% ropivacaine per side
Experimental group
Treatment:
Drug: Ropivacaine
Drug: Ropivacaine
Drug: Ropivacaine
40mLs of 0.25% ropivacaine per side
Experimental group
Treatment:
Drug: Ropivacaine
Drug: Ropivacaine
Drug: Ropivacaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems